Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Heyman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Southern Medical Journal|July 1, 1988
Procainamide-induced lupus anticoagulantM R Heyman, R H Flores, B B Edelman, et al.
American Journal of Hematology|July 1, 1988
Failure of high-dose i.v. gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitorsM R Heyman, A Chakravarthy, B B Edelman, et al.
Southern Medical Journal|November 1, 1986
Reacting appropriately to thrombocytopenia in pregnancyD A Nagey, L S Alger, B B Edelman, et al.
Hematologic Pathology|January 1, 1990
Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activationS W Needleman, S M Mane, J C Gutheil, et al.
Journal of Biological Response Modifiers|December 1, 1984
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancerS A Sherwin, K A Foon, P G Abrams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment ProgramP McLaughlin, A J Grillo-López, B K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment programP McLaughlin, A J Grillo-López, B K Link, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Southern Medical Journal|July 1, 1988
Procainamide-induced lupus anticoagulantM R Heyman, R H Flores, B B Edelman, et al.
American Journal of Hematology|July 1, 1988
Failure of high-dose i.v. gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitorsM R Heyman, A Chakravarthy, B B Edelman, et al.
Southern Medical Journal|November 1, 1986
Reacting appropriately to thrombocytopenia in pregnancyD A Nagey, L S Alger, B B Edelman, et al.
Hematologic Pathology|January 1, 1990
Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activationS W Needleman, S M Mane, J C Gutheil, et al.
Journal of Biological Response Modifiers|December 1, 1984
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancerS A Sherwin, K A Foon, P G Abrams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment ProgramP McLaughlin, A J Grillo-López, B K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment programP McLaughlin, A J Grillo-López, B K Link, et al.
Pageof 2